NASDAQ: PALIPalisade Bio Inc Stock Ownership - Who owns Palisade Bio?
Insider buying vs selling
Have Palisade Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John David Finley | CEO CFO Director | 2023-04-03 | 435 | $2.01 | $874.35Sell |
| Robert Curtis McRae | Chief Operating Officer | 2023-04-03 | 270 | $2.00 | $540.00Sell |
| John David Finley | Chief Financial Officer | 2022-09-01 | 19,481 | $0.14 | $2.81kBuy |
| John David Finley | Chief Financial Officer | 2022-08-23 | 7,350 | $0.16 | $1.18kBuy |
| John David Finley | Chief Financial Officer | 2022-08-16 | 100,000 | $0.25 | $25.00kBuy |
| Thomas Hallam | Chief Executive Officer | 2022-08-16 | 40,000 | $0.25 | $10.00kBuy |
PALI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PALI insiders and whales buy or sell their stock.
PALI Shareholders
What type of owners hold Palisade Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Richard Garr | 29.66% | 1,986,304 | $2.76M | Insider |
| Regional Medical Center Yuma | 27.09% | 1,814,375 | $2.52M | Insider |
| Princeton Capital Corp | 19.32% | 1,293,814 | $1.80M | Insider |
| Stanley Westreich | 17.82% | 1,193,281 | $1.66M | Insider |
| Karl Johe | 13.89% | 930,373 | $1.29M | Insider |
| Robert J. Trenschel | 4.77% | 319,478 | $444.07k | Insider |
| Sandford D. Smith | 3.28% | 219,916 | $305.68k | Insider |
| John Conron | 1.72% | 115,492 | $160.53k | Insider |
| Catherine A. Sohn | 1.60% | 106,952 | $148.66k | Insider |
| Scott Varde Ogilvie | 1.28% | 86,020 | $119.57k | Insider |
PALI vs Biotech Stocks
Palisade Bio Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.